Clinical trials / NCT06274801
NCT06274801Phase 3Recruiting

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

Study sponsor: Gossamer Bio USA, Inc.

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov recordCSV export · Pro
Primary completion2026-12Estimated
Enrollment · participants330Estimated
Source updated2026-07-29Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 3 fields changed

Participant count type changed

− Before

Actual

+ After

Estimated

Enrollment · participant count changed

− Before

316 participants (actual)

+ After

330 participants (planned)

Recruitment status changed

− Before

Active not recruiting

+ After

Recruiting

Check registry source

· 3 fields changed

Participant count type changed

− Before

Estimated

+ After

Actual

Enrollment · participant count changed

− Before

300 participants (planned)

+ After

316 participants (actual)

Recruitment status changed

− Before

Recruiting

+ After

Active not recruiting

Check registry source